指南与共识脑血管病

缺血性卒中血管内取栓围术期免疫调节共识综述

Consensus Review of Perioperative Immune Modulation for Endovascular Thrombectomy Following Ischemic Stroke.
指南 / 共识 · Stroke · 2026-02-02

本共识综述由国际多学科专家组制定,综合临床前与临床证据评估多种免疫调节策略对缺血性卒中血管内取栓术后功能预后的改善潜力,旨在为未来围术期免疫治疗研究提供基础参考。

要点

  • 取栓围术期是麻醉策略通过血流动力学与免疫调节影响恢复的关键窗口。
  • 无复流现象与炎症级联激活是取栓后长期神经功能不良的重要归因。
  • 共识旨在为未来新型围术期免疫治疗研发提供基础参考。

核心结论

  • 围术期免疫调节策略有望改善血管内取栓术后缺血性卒中患者的功能预后,但需进一步研究验证。

研究设计与样本

  • 本共识综述由国际多学科专家组制定,综合临床前与临床证据进行评估。

主要发现

  • 取栓后许多患者长期神经功能预后不良,常归因于无复流现象与炎症级联激活。

临床怎么用

  • 围术期麻醉管理(全麻或清醒镇静)可能通过血流动力学控制与免疫调节影响患者恢复。

局限性

  • 本共识为综述性文件,旨在提供基础参考,未报告具体研究样本量或定量阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ischemic stroke is a major global health burden, leading to considerable mortality and long-term disability. Endovascular thrombectomy and mechanical recanalization have revolutionized acute stroke care. Nonetheless, many patients experience poor long-term neurological outcomes, which are often attributed to the no-reflow phenomenon and activation of inflammatory cascades. The perioperative period of endovascular thrombectomy, managed under either general anesthesia or conscious sedation, represents a critical window where anesthetic strategies may influence recovery through hemodynamic control and possibly immune modulation. This consensus review was generated by an international multidisciplinary expert group and synthesizes preclinical and clinical evidence to evaluate the promise of various immunomodulatory strategies for improving functional outcomes in patients with ischemic stroke following endovascular thrombectomy. Our goal is to provide a foundational reference for future research and development of novel perioperative immune therapies for patients with endovascular thrombectomy.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Cai L, Li Y, Wang C, et al. Consensus Review of Perioperative Immune Modulation for Endovascular Thrombectomy Following Ischemic Stroke. Stroke. 2026. PMID: 41623081. doi:10.1161/STROKEAHA.125.051556

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。